| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | FLEXION THERAPEUTICS INC | 50,000 | 1,126,000 | 0.47% | ||
| 52 | HAEMONETICS CORP MASS COM | 25,000 | 1,123,000 | 0.47% | ||
| 53 | NEKTAR THERAPEUTICS COM | 100,000 | 1,100,000 | 0.46% | ||
| 54 | DBV TECHNOLOGIES S A | 45,000 | 1,051,000 | 0.44% | ||
| 55 | PACIFIC BIOSCIENCES CALIF IN | 150,000 | 876,000 | 0.37% | ||
| 56 | ENDOLOGIX INC | 50,000 | 854,000 | 0.36% | ||
| 57 | ORASURE TECHNOLOGIES INC | 105,000 | 687,000 | 0.29% | ||
| 58 | TESARO INCORPORATED | 10,000 | 574,000 | 0.24% | ||
| 59 | DEPOMED INC | 25,000 | 560,000 | 0.24% | ||
| 60 | TETRALOGIC PHARMA CO | 100,000 | 438,000 | 0.18% | ||
| 61 | MEI PHARMA INC | 150,000 | 269,000 | 0.11% | ||
| 62 | IMMUNOMEDICS INCORPORATED | 50,000 | 192,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-15-000011, filed 2015.06.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
